Combination Chemotherapy and Peripheral Stem Cell Transplantation Followed by Interleukin-2 and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer - Related Studies

Combination Chemotherapy and Peripheral Stem Cell Transplantation Followed by Interleukin-2 and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer

This study is ongoing, but not recruiting participants.

Study NCT00003199. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Breast Cancer

2	Additional conditions recognized in this trial
		Breast Neoplasms

3	More general conditions related to this trial
		Breast Diseases
		Neoplasms
		Neoplasms by Site
		Skin Diseases

4	Interventions listed in this trial
		aldesleukin
		busulfan
		melphalan
		sargramostim
		tamoxifen citrate
		thiotepa
		radiation therapy

5	Additional drug interventions recognized in this trial
		Tamoxifen

6	More general drug interventions related to this trial
		Alkylating Agents
		Anti-HIV Agents
		Anti-Infective Agents
		Anti-Retroviral Agents
		Antineoplastic Agents
		Antineoplastic Agents, Alkylating
		Antineoplastic Agents, Hormonal
		Antiviral Agents
		Bone Density Conservation Agents
		Estrogen Antagonists
		Estrogen Receptor Modulators
		Hormone Antagonists
		Hormones, Hormone Substitutes, and Hormone Antagonists
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Myeloablative Agonists
		Pharmacologic Actions
		Physiological Effects of Drugs
		Selective Estrogen Receptor Modulators
		Therapeutic Uses

7	Sponsors listed in this trial
		Fred Hutchinson Cancer Research Center
		National Cancer Institute (NCI)